Health & Fit Canada records second case of rare blood clot after AstraZeneca shot
Thailand Approves AstraZeneca: Southeast Asia Vaccine Tracker
AstraZeneca Plc’s vaccine won approval from Thailand, becoming the third company to clear regulatory requirements for use in Southeast Asia. Thousands of people in Singapore and Indonesia have already received the Pfizer Inc.-BioNTech SE and Sinovac Biotech Ltd. vaccines, and their neighbors are signing more deals to procure supplies. China is also giving free vaccines to countries like the Philippines and Cambodia.Indonesia, Southeast Asia’s biggest and most populous economy, started its coronavirus vaccination program on Jan.
Canadian health authorities said Saturday the country has recorded a second case of rare but serious blood clotting linked to AstraZeneca's Covid-19 vaccine, but still recommend the shot for use.
The patient, who lives in the western province of Alberta and received a version of the AstraZeneca vaccine supplied by the Serum Institute of India, "has received treatment and is recovering," Canadian health authorities wrote on Twitter.
Canada reported its first case of blood clotting associated with low platelets on Tuesday in a Quebec woman who received the same shot.
AstraZeneca vaccine: EU regulators recommend authorization of Covid-19 shot
The European Union's medicines regulator on Friday recommended authorizing the Oxford-AstraZeneca Covid-19 vaccine, capping off a turbulent week which saw the bloc attack the drugmaker over delays to supply. © Vincenzo Pinto/AFP/Getty Images A laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 at the Italian biologics manufacturing facility of multinational corporation Catalent in Anagni, southea
Blood clot formations linked to the AstraZeneca vaccine "remain very rare" and Canada still believes that the vaccine's benefits "outweigh the potential risks," Health Canada and the Public Health Agency of Canada said.
Canada's health authorities added that they would "continue to monitor the use of all #COVID19 vaccines closely and examine and assess any new safety concerns."
Gallery: Early Signs You Have Lung Cancer (ETNT Health)
At the end of March Canada's National Advisory Committee on Immunization (NACI) recommended suspending the use of the AstraZeneca vaccine in people under the age of 55 while it evaluated the risks.
However Health Canada said Wednesday that according to its analysis, limiting the use of the vaccine to certain populations was not necessary for the moment.
After a slow start, Canada's vaccine campaign is gaining momentum. To date, 23.3 percent of the Canadian population has received at least one vaccine dose according to the Covid-19 Tracker Canada website.
The country is facing a third coronavirus wave, however, that has recently forced provinces to tighten restrictions.
Ontario, which has the highest number of cases, announced Friday it would strengthen and extend lockdown measures until May 19, and also close its borders with the provinces of Quebec and Manitoba beginning Monday.
Canada has recorded more than 1.1 million cases of Covid-19 since the start of the pandemic and more than 23,500 deaths.
Doctors Explain the Johnson & Johnson Vaccine’s Link to Extremely Rare Blood Clots .
The CDC and FDA are reviewing data involving six reported cases out of more than 6.8 million doses.“As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. The CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine,” a joint statement from the agencies reads.“In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia).